Mus vs Zambia: Previously treated cases tested for RR-/MDR-TB (%)
Mus
100.0%
in 2022
Zambia
100.0%
in 2024
Mus rank
1st
Zambia rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Mus
- Zambia
How they compare
Mus currently reports 100.0% against 100.0% in Zambia, a difference of 0.0%.
Across all 11 years both countries report, Mus has been ahead every year.
Mus ranks 1st and Zambia ranks 1st of 2 regions.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 6.9% | 93.1% | Mus |
| 2010s | 92.0% | 24.0% | 68.0% | Mus |
| 2020s | 100.0% | 72.7% | 27.3% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mus or Zambia?
- Mus, at 100.0% against 100.0% in Zambia as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mus and Zambia?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Zambia?
- 11 years are reported by both, from 2007 to 2022.
- How do Mus and Zambia rank globally for previously treated cases tested for rr-/mdr-tb?
- Mus ranks 1st and Zambia ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.